Published in Chem Pharm Bull (Tokyo) on July 01, 1993
Chlorogenic acid and rutin play a major role in the in vivo anti-diabetic activity of Morus alba leaf extract on type II diabetic rats. PLoS One (2012) 1.03
Bioactive constituents from the roots of Panax japonicus var. major and development of a LC-MS/MS method for distinguishing between natural and artifactual compounds. J Nat Prod (2011) 0.83
Poisoning due to organophosphate insecticides. Acute and chronic manifestations. Am J Med (1971) 5.20
Prolonged weakness after long-term infusion of vecuronium bromide. Ann Intern Med (1992) 3.36
Recent progress in pharmacological research of propolis. Phytother Res (2001) 2.72
Neonatal myasthenia gravis: report of two cases and review of the literature. Pediatrics (1970) 2.29
Staining for nerve fiber and cholinesterase activity in fresh frozen sections. Am J Clin Pathol (1967) 2.01
Cloning and expression of a cDNA for mouse prostaglandin E receptor EP3 subtype. J Biol Chem (1992) 1.75
Cloning and expression of cDNA for a mouse EP1 subtype of prostaglandin E receptor. J Biol Chem (1993) 1.72
The course of myasthenia gravis and therapies affecting outcome. Ann N Y Acad Sci (1987) 1.62
Cloning and expression of a cDNA for mouse prostaglandin E receptor EP2 subtype. J Biol Chem (1993) 1.61
High-dose intravenous immunoglobulin in the management of myasthenia gravis. Arch Intern Med (1986) 1.56
Psychosocial factors affecting psychosomatic symptoms in Japanese schoolchildren. Pediatr Int (2000) 1.54
Processing of nux vomica. II. Changes in alkaloid composition of the seeds of Strychnos nux-vomica on traditional drug-processing. Chem Pharm Bull (Tokyo) (1990) 1.52
Targeting endogenous platelet-derived growth factor B-chain by adenovirus-mediated gene transfer potently inhibits in vivo smooth muscle proliferation after arterial injury. Gene Ther (1999) 1.51
Volcanic production of polyphosphates and its relevance to prebiotic evolution. Nature (1991) 1.47
Cholinesterase inhibition by organophosphorus compounds and its clinical effects. Bull World Health Organ (1971) 1.43
Potent inhibitors of tyrosinase activity and melanin biosynthesis from Rheum officinale. Planta Med (1995) 1.39
Pervanadate [peroxide(s) of vanadate] mimics insulin action in rat adipocytes via activation of the insulin receptor tyrosine kinase. Biochemistry (1989) 1.38
Familial myasthenia gravis. Report of 27 patients in 12 families and review of 164 patients in 73 families. Arch Neurol (1971) 1.38
Constituents of the Vietnamese medicinal plant Orthosiphon stamineus. Chem Pharm Bull (Tokyo) (2000) 1.38
Two isoforms of the EP3 receptor with different carboxyl-terminal domains. Identical ligand binding properties and different coupling properties with Gi proteins. J Biol Chem (1993) 1.37
Anastomotic aneurysms after surgical treatment of Takayasu's arteritis: a 40-year experience. J Vasc Surg (1998) 1.35
Third isoform of the prostaglandin-E-receptor EP3 subtype with different C-terminal tail coupling to both stimulation and inhibition of adenylate cyclase. Eur J Biochem (1993) 1.33
In situ hybridization studies of prostacyclin receptor mRNA expression in various mouse organs. Br J Pharmacol (1995) 1.33
Four di-O-caffeoyl quinic acid derivatives from propolis. Potent hepatoprotective activity in experimental liver injury models. Biol Pharm Bull (1996) 1.28
Hypoglycemic effect of the water extract of Piper sarmentosum in rats. J Ethnopharmacol (1998) 1.28
Myasthenia gravis in patients with thymoma, with particular reference to onset after thymectomy. Medicine (Baltimore) (1978) 1.28
The natural course of myasthenia gravis and effect of therapeutic measures. Ann N Y Acad Sci (1981) 1.27
Studies on dental caries prevention by traditional medicines. VIII. Inhibitory effect of various tannins on glucan synthesis by glucosyltransferase from Streptococcus mutans. Chem Pharm Bull (Tokyo) (1986) 1.26
Idiopathic giant cell polymyositis. Report of a case and review of the syndrome. Arch Neurol (1974) 1.25
Hepatoprotective and anti-Helicobacter pylori activities of constituents from Brazilian propolis. Phytomedicine (2001) 1.24
Anti-inflammatory effects of emodin from ventilago leiocarpa. Am J Chin Med (1996) 1.23
Celecoxib upregulates endoplasmic reticulum chaperones that inhibit celecoxib-induced apoptosis in human gastric cells. Oncogene (2006) 1.23
Role of nitric oxide towards vasodilator effects of substance P and ATP in human forearm vessels. Clin Sci (Lond) (1997) 1.22
Effect of tea polyphenols on glucan synthesis by glucosyltransferase from Streptococcus mutans. Chem Pharm Bull (Tokyo) (1990) 1.21
Clostridium botulinum C3 ADP-ribosyltransferase gene. Cloning, sequencing, and expression of a functional protein in Escherichia coli. J Biol Chem (1991) 1.20
Distribution of the messenger RNA for the prostaglandin E receptor subtype EP3 in the mouse nervous system. Neuroscience (1994) 1.19
Repetitive cocaine administration decreases neurogenesis in adult rat hippocampus. Ann N Y Acad Sci (2004) 1.19
Cholinesterase activity of the motor endplate in isolated muscle membrane. J Neurochem (1968) 1.19
Peroxide(s) of vanadium: a novel and potent insulin-mimetic agent which activates the insulin receptor kinase. Biochem Biophys Res Commun (1987) 1.16
Cloning and expression of a cDNA for mouse prostaglandin F receptor. J Biol Chem (1994) 1.15
High-dose intravenous methylprednisolone in myasthenia gravis. Arch Neurol (1985) 1.14
Intracapsular components do not change hip proprioception. J Bone Joint Surg Br (1999) 1.13
Analysis of a thread used in the Kshara Sutra treatment in the Ayurvedic medicinal system. J Ethnopharmacol (1990) 1.12
Antioxidative effects of phenylethanoids from Cistanche deserticola. Biol Pharm Bull (1996) 1.11
Metabolism of glycyrrhizin by human intestinal flora. Planta Med (1983) 1.11
Inhibitory effects of Egyptian folk medicines on human immunodeficiency virus (HIV) reverse transcriptase. Chem Pharm Bull (Tokyo) (1995) 1.11
Chronic proximal spinal muscular atrophy. J Neurol Sci (1970) 1.09
Corticotropin in generalized myasthenia gravis. Effect of short, intensive courses. JAMA (1966) 1.08
Thromboxane A2 receptor is highly expressed in mouse immature thymocytes and mediates DNA fragmentation and apoptosis. J Exp Med (1993) 1.07
Diffuse myopathy related to meperidine addiction in a mother and daughter. Arch Neurol (1968) 1.07
Cytotoxic, hepatoprotective and free radical scavenging effects of propolis from Brazil, Peru, the Netherlands and China. J Ethnopharmacol (2000) 1.07
Chondrodystrophic myotonia: report of two cases. Myotonia, dwarfism, diffuse bone disease, and unusual ocular and facial abnormalities. Arch Neurol (1970) 1.07
Chemical constituents of Brazilian propolis and their cytotoxic activities. J Nat Prod (1998) 1.06
Mechanism of antihepatotoxic activity of glycyrrhizin. I: Effect on free radical generation and lipid peroxidation. Planta Med (1984) 1.04
Two novel cytotoxic benzofuran derivatives from Brazilian propolis. J Nat Prod (2000) 1.04
Identification of prostaglandin E receptor 'EP2' cloned from mastocytoma cells EP4 subtype. FEBS Lett (1995) 1.04
Distinct cellular localization of mRNAs for three subtypes of prostaglandin E receptor in kidney. Am J Physiol (1994) 1.04
Metabolism of glycyrrhizin by human intestinal flora. II. Isolation and characterization of human intestinal bacteria capable of metabolizing glycyrrhizin and related compounds. Chem Pharm Bull (Tokyo) (1985) 1.04
Anti-herpes simplex virus activity of moronic acid purified from Rhus javanica in vitro and in vivo. J Pharmacol Exp Ther (1999) 1.03
Hepatoprotective activity of phenylethanoids from Cistanche deserticola. Planta Med (1998) 1.02
Three-dimensional kinematics of the human knee with intracortical pin fixation. Clin Orthop Relat Res (1997) 1.02
Triterpene saponins from Vietnamese ginseng (Panax vietnamensis) and their hepatocytoprotective activity. J Nat Prod (2001) 1.02
Conduction velocity in the ulnar nerve in hemiplegic patients. J Neurol Sci (1971) 1.01
Highly selective antibacterial activity of novel alkyl quinolone alkaloids from a Chinese herbal medicine, Gosyuyu (Wu-Chu-Yu), against Helicobacter pylori in vitro. Microbiol Immunol (2000) 1.00
Corticosteroids in management of severe, generalized myasthenia gravis. Effectiveness and comparison with corticotropin therapy. Neurology (1972) 1.00
Preventive effect of lithospermate B from Salvia miltiorhiza on experimental hepatitis induced by carbon tetrachloride or D-galactosamine/lipopolysaccharide. Planta Med (1997) 1.00
Constituents of the roots of Boerhaavia diffusa L. III. Identification of Ca2+ channel antagonistic compound from the methanol extract. Chem Pharm Bull (Tokyo) (1991) 0.99
Screening of Chinese herbal drug extracts for inhibitory activity on nitric oxide production and identification of an active compound of Zanthoxylum bungeanum. J Ethnopharmacol (2001) 0.99
Stimulation of insulin-like growth factor II receptor binding and insulin receptor kinase activity in rat adipocytes. Effects of vanadate and H2O2. J Biol Chem (1987) 0.99
Antiviral traditional medicines against herpes simplex virus (HSV-1), poliovirus, and measles virus in vitro and their therapeutic efficacies for HSV-1 infection in mice. Antiviral Res (1993) 0.99
Glial fibrillary acidic protein-expressing neural progenitors give rise to immature neurons via early intermediate progenitors expressing both glial fibrillary acidic protein and neuronal markers in the adult hippocampus. Neuroscience (2009) 0.99
Epicalyxin F and calyxin I: two novel antiproliferative diarylheptanoids from the seeds of Alpinia blepharocalyx. Org Lett (1999) 0.98
Inhibition of nitric oxide by phenylethanoids in activated macrophages. Eur J Pharmacol (2000) 0.98
Cholinesterase activity of motor end plate in human skeletal muscle. J Clin Invest (1970) 0.98
Malathion poisoning. A fatal case with cardiac manifestations. Arch Environ Health (1970) 0.97
Effect of Cleistanthus collinus leaf extract on neuromuscular function of the isolated mouse phrenic nerve-diaphragm. Toxicon (1989) 0.97
Processing of nux vomica. VII. Antinociceptive effects of crude alkaloids from the processed and unprocessed seeds of Strychnos nux-vomica in mice. Biol Pharm Bull (1996) 0.97
A simple and novel peptide bond formation by copper (II) complex. Tetrahedron Lett (1970) 0.96
Liquid chromatography-mass spectrometry analysis of propolis. Phytochem Anal (2002) 0.96
Effect of serum and serum globulin of patients with myasthenia gravis on neuromuscular transmission. Neurology (1969) 0.96
Eleven novel diarylheptanoids and two unusual diarylheptanoid derivatives from the seeds of Alpinia blepharocalyx. J Nat Prod (2001) 0.96
Corticotropin therapy in myasthenia gravis: effects, indications, and limitations. Neurology (1971) 0.94
Bellidifolin: a potent hypoglycemic agent in streptozotocin (STZ)-induced diabetic rats from Swertia japonica. Planta Med (1994) 0.94
Molecular cloning of human prostacyclin receptor cDNA and its gene expression in the cardiovascular system. Circulation (1994) 0.94
Failure of neuromuscular transmission and contractility during muscle fatigue. Muscle Nerve (1985) 0.94
Autoantibodies and myasthenia gravis, with special reference to muscle ribonucleoprotein. Ann N Y Acad Sci (1966) 0.93
A rho gene product in human blood platelets. I. Identification of the platelet substrate for botulinum C3 ADP-ribosyltransferase as rhoA protein. J Biol Chem (1992) 0.93
Cloning and expression of a cDNA for the human prostacyclin receptor. FEBS Lett (1994) 0.93
Antiproliferative activity of diarylheptanoids from the seeds of Alpinia blepharocalyx. Biol Pharm Bull (2001) 0.93